Contributing to our community in 2020

Posted:
17
December 2020

Richmond Pharmacology has a long-standing tradition of supporting local, national, and international charities and 2020 is no exception.

2020 has been a year like no other.

As the COVID-19 pandemic swept across the globe we witnessed an international health crisis which commanded the attention of health care professionals, Governments, businesses, and institutions.

Charities saw a fall in donations which has impacted vital research,care and education. It is more important than ever to raise money for those less fortunate and help continue vital charitable services.

Richmond Pharmacology has a long-standing tradition of supporting local, national, and international charities and 2020 is no exception. We have made substantial charitable contributions to a number of charities this year including: Global’s Make Some Noise, Diabetes UK, Robes, the British Heart Foundation and Practical Action. The causes are varied but close to the hearts of our staff and sponsors.

A message from Robes

"Thank you to all who donated to the Robes project via Richmond Pharmacology this year, very much indeed for your generosity. You collectively raised the amazing sum of £5,500 which is absolutely wonderful and will be a huge help for Robes this year."

Canon Giles Goddard, St John’s Church, Waterloo

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

What 20 years of clinical research has taught us about our industry and the future of drug development

June 9, 2021
As Richmond Pharmacology approaches its 20th anniversary our co-founder and CEO reflects on the developments, regulatory changes, and innovations within the life science industry in an article in the PharmaTimes.
Read more

Do we still need challenge trials with COVID-19?

April 21, 2021
Nir Eyal and colleagues suggested that the initiation of COVID-19 challenge trials in response to the UK governments’ call in 2020 remained relevant and important despite the development of approved vaccines and the introduction of an aggressive, UK-wide vaccination policy.
Read more

Novel rate-controlled fentanyl patch shows promise in phase I clinical trial

April 1, 2021
Our expertise in ethnic differences and access to over 12,000 first generation Japanese volunteers accelerated our ability to provide robust clinical trial data to support future applications of new chronic pain medicines to the Japanese drug market.
Read more